News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Spellman David A
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/18/2023 |
4
| Spellman David A (SVP, CFO and Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 63,567 shares
@ $1.068, valued at
$67.9k
|
|
| 05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/03/2023 |
4
| Spellman David A (SVP, CFO and Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 6,400 shares
@ $0.8775, valued at
$5.6k
Sold 810 shares
@ $0.8775, valued at
$710.8 |
|
| 03/01/2023 |
4
| Spellman David A (SVP, CFO and Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 7,539 shares
@ $0.8132, valued at
$6.1k
|
|
| 02/02/2023 |
4
| Spellman David A (SVP, CFO and Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 196,200 shares
@ $0
Granted 294,300 options to buy
@ $0.63, valued at
$185.4k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2021 |
4
| Spellman David A (SVP, CFO and Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $2.88, valued at
$576k
|
|
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/25/2019 |
4
| Spellman David A (CFO) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $3.51, valued at
$351k
|
|
| 03/14/2018 |
4
| Spellman David A (CFO) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $13.97, valued at
$2.1M
|
|
| 03/14/2018 |
3
| Spellman David A (CFO) has filed a Form 3 on Mersana Therapeutics, Inc. |
|
|